Aquinox Pharma Balance Sheet - Quarterly (NASDAQ:AQXP)

Add to My Stocks
$2.77 $0.07 (2.46%) AQXP stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Aquinox Pharma balance sheet. Financial strength can be guaged by performing Aquinox Pharma stock analysis and by analyzing the balance sheet. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Aquinox Pharma revenue Aquinox Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Aquinox Pharma balance sheet for 2018 Q2 shows cash on hand of $99.13M. The company has a debt to equity ratio of .

View and download Aquinox Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities3.01M26.05M56.05M72.59M104.13M100.66M70.75M59.71M44.08M33.02M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment--1.44M---1.02M---
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances-----20M50.04M16.66M32.66M38.62M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable13.35M9.35M10.95M6.99M8.12M5.82M9.51M8.56M8.49M5.72M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus300.89M298.97M297.45M296.42M295.21M293.78M293.11M292.4M220.9M220.41M
Retained Earnings-210.21M-213.12M-198.5M-182.23M-170.4M-156.63M-148.27M-137.03M-128.88M-117.98M
Treasury Stock----------
Other Liabilities--0.02M-0.07M-0.1M-0.2M-0.2M-0.16M-0.01M--0.04M
Shareholders Equity90.68M85.82M98.88M114.09M124.6M136.94M144.66M155.36M92.08M102.38M
Total Liabilities & Shareholders Equity104.43M95.62M110.32M121.6M133.28M143.32M154.38M164.06M100.7M108.21M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Aquinox Pharma stock price by looking at Aquinox Pharma historical stock prices. One can compare PE with industry average by looking at the Aquinox Pharma PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the Aquinox Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Aquinox Pharma had total assets of $104.43M.
  • Liabilities: The total liabilities of Aquinox Pharma for the quarter 2018 Q2 total to $13.75M. Liabilities for a company like Aquinox Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Aquinox Pharma Balance Sheet - Key Ratios